Skip to content

Author

Kelly S. Klega

We have 3 of 40 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

A Subset of FOXO1‐Fusion Negative Rhabdomyosarcoma With Round Cell (Alveolar) and “Burkitt‐Like” Morphology Is Associated With High Amplification of MYCL: A Report From the Children's Oncology Group

Alveolar rhabdomyosarcoma (ARMS) is a distinct histologic subtype of rhabdomyosarcoma, associated with the presence of a PAX3 or PAX7::FOXO1 gene fusion in approximately 80% of cases. Adverse outcomes for patients with ARMS are associated with the presence of a FOXO1 gene fusion; however, additional genetic markers are...

Sonja D. Chen, Wei Xue, Cora A. Ricker et al. · 0 citations
Open access Sep 2026

Circulating Tumor DNA Profiling Defines Risk Classification in Patients With Ewing Sarcoma: A Report From the Children's Oncology Group and the LEOPARD Study.

PURPOSE Identification of discrete risk groups remains a high priority for patients with Ewing sarcoma (EWS). We sought to prospectively validate circulating tumor DNA (ctDNA) as a prognostic factor and develop clinical-molecular risk groups. METHODS We conducted a prospective investigator-initiated biology study for...

D. Shulman, Kelly S. Klega, Nan Chen et al. · 0 citations
Open access Sep 2026

Clustered structural variant hotspots enable oncogenic addiction and plasticity in osteosarcoma

Across 236 whole-genome sequencing osteosarcoma samples, five genomic hotspots of clustered structural variation collectively altered in 58% of tumors were uncovered, and localized transcriptional dysregulation at hotspot event loci was found, linking these structural alterations to a less differentiated cell state.

Shreya Raman, Thorsten Kaltenbacher, David Merrell et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.